Squarepoint’s The Oncology Institute TOI Stock Holding History
Bought
Maintained
Sold
Other funds holding TOI
VCM
DM
KWM
JAIC
WC
CP
Squarepoint's TOI Position: Q1 2026 in Review
Squarepoint reduced its The Oncology Institute (TOI) stake by 61% in Q1 2026, selling an estimated $116K and leaving 23,831 shares worth $73.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4111.
Squarepoint first reported a position in TOI in Q4 2023 and has held it in 5 quarters since. The position peaked at $498K in Q3 2025. 115 funds tracked by Wall St. Rank hold TOI as of Q1 2026.
- Squarepoint held 23,831 shares of The Oncology Institute worth $73.2K as of Q1 2026.
- Squarepoint sold 37,933 The Oncology Institute shares in Q1 2026, an estimated $116K.
- The Oncology Institute made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #4111 holding.
- Squarepoint first reported a position in The Oncology Institute in Q4 2023 and has held it in 5 quarters since.
- Squarepoint's The Oncology Institute position peaked at $498K in Q3 2025.
- 115 funds tracked by Wall St. Rank held The Oncology Institute as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.